Detalhe da pesquisa
1.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Cardiovasc Diabetol
; 23(1): 104, 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38504284
2.
Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactions.
Br J Clin Pharmacol
; 90(4): 942-958, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38148609
3.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36927451
4.
New strategies to improve clinical outcomes for diabetic kidney disease.
BMC Med
; 20(1): 337, 2022 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36210442
5.
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Cardiovasc Diabetol
; 21(1): 50, 2022 04 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35395808
6.
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Cardiovasc Diabetol
; 20(1): 75, 2021 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33789663
7.
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.
Diabetes Metab Res Rev
; 37(6): e3418, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33098260
8.
Diabetic Macular Edema in Diabetological Practices. / Diabetisches Makulaödem in diabetologischen Schwerpunktpraxen.
Klin Monbl Augenheilkd
; 237(11): 1320-1325, 2020 Nov.
Artigo
Inglês, Alemão
| MEDLINE | ID: mdl-33202460
9.
Sequential Treatment Escalation with Dapagliflozin and Saxagliptin Improves Beta Cell Function in Type 2 Diabetic Patients on Previous Metformin Treatment: An Exploratory Mechanistic Study.
Horm Metab Res
; 50(5): 403-407, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29727906
10.
Effects on α- and ß-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
Diabetes Obes Metab
; 19(4): 489-495, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28009472
11.
Euglycaemic glucose clamp: what it can and cannot do, and how to do it.
Diabetes Obes Metab
; 18(10): 962-72, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27324560
12.
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.
Lancet
; 384(9951): 1349-57, 2014 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-25018121
13.
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.
Lancet
; 381(9861): 117-24, 2013 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23141817
14.
Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Diabetes Metab Res Rev
; 30(7): 582-9, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24459063
15.
Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.
Cardiovasc Diabetol
; 12: 59, 2013 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-23565740
16.
Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials.
J Diabetes Sci Technol
; 17(6): 1649-1661, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35818669
17.
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
Metabolism
; 143: 155550, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36958671
18.
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus.
J Diabetes Sci Technol
; : 19322968231204584, 2023 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37937585
19.
Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR.
Clin Lab
; 58(9-10): 959-71, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23163112
20.
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.
Cardiovasc Diabetol
; 10: 65, 2011 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-21756323